FAIM
AQST icon

Financial Advocates Investment Management’s Aquestive Therapeutics AQST Stock Holding History

Financial Advocates Investment Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,000
Closed -$148K – 636
2025
Q1 		$148K Buy
51,000
+1,000
+2% +$3.03K 0.01% 693
2024
Q4 		$178K Buy
50,000
+11,000
+28% +$50.7K 0.01% 707
2024
Q3 		$194K Buy
39,000
+5,000
+15% +$19.5K 0.01% 718
2024
Q2 		$88.4K Buy
34,000
+14,000
+70% +$46.8K 0.01% 713
2024
Q1 		$85.2K Hold
20,000
– – ﹤0.01% 742
2023
Q4 		$40.4K Hold
20,000
– – ﹤0.01% 717
2023
Q3 		$30.6K Hold
20,000
– – ﹤0.01% 692
2023
Q2 		$33K Sell
20,000
-5,000
-20% -$9.04K ﹤0.01% 689
2023
Q1 		$28.5K Sell
25,000
-7,000
-22% -$6.07K ﹤0.01% 731
2022
Q4 		$28.9K Buy
32,000
+5,000
+19% +$4.7K ﹤0.01% 740
2022
Q3 		$32K Hold
27,000
– – ﹤0.01% 738
2022
Q2 		$17K Buy
27,000
+7,500
+38% +$9.98K ﹤0.01% 676
2022
Q1 		$51K Hold
19,500
– – ﹤0.01% 717
2021
Q4 		$76K Buy
19,500
+2,500
+15% +$12.5K ﹤0.01% 753
2021
Q3 		$74K Hold
17,000
– – 0.01% 731
2021
Q2 		$67K Buy
17,000
+4,000
+31% +$16K ﹤0.01% 724
2021
Q1 		$68K Sell
13,000
-1,200
-8% -$6.38K ﹤0.01% 737
2020
Q4 		$76K Buy
+14,200
New +$85.1K 0.01% 704

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Financial Advocates Investment Management's AQST Position: Q2 2025 in Review

Financial Advocates Investment Management sold out of Aquestive Therapeutics (AQST) in Q2 2025, closing a stake of 51,000 shares — an estimated $148K sold.

Financial Advocates Investment Management first reported a position in AQST in Q4 2020 and held it in 18 quarters. The position peaked at $194K in Q3 2024. 116 funds tracked by Wall St. Rank hold AQST as of Q2 2025.

  • Financial Advocates Investment Management reported no remaining Aquestive Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Financial Advocates Investment Management sold 51,000 Aquestive Therapeutics shares in Q2 2025, an estimated $148K.
  • Financial Advocates Investment Management first reported a position in Aquestive Therapeutics in Q4 2020 and held it in 18 quarters.
  • Financial Advocates Investment Management's Aquestive Therapeutics position peaked at $194K in Q3 2024.
  • 116 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2025.

Based on Financial Advocates Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.